HUM and ELV Related Headlines
Go Back- Health insurers slide after 2027 Medicare Advantage payments proposal underwhelms
- S&P 500 marks closing record as corporate earnings roll in; Medicare rates hit insurers
- Cantor Fitzgerald Reiterates Neutral on Molina Healthcare (MOH), Highlights 2026 Stars Progress
- Mizuho Positive on CVS Health (CVS): 'We believe this is a positive for CVS'
- Important Notice to Long-Term Shareholders of Elevance Health, Inc. (NYSE: ELV); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Inves
- Cantor Fitzgerald Reiterates Neutral Rating on Humana (HUM)
- UnitedHealth projects most Medicare Advantage members in top-rated plans by 2027
- Centene (CNC) PT Lowered to $52 at BofA Securities
- Centene stock tumbles after withdrawal of 2025 guidance
- Humana (HUM) Healthcare stocks on watch after Centene withdraws guidance
- Health Insurers To Promise Changes To Preapproval Process - WSJ
